tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LTRN Stock Latest News

Lantern Pharma Discusses Q3 Financial Results Webinar
Company AnnouncementsLantern Pharma Discusses Q3 Financial Results Webinar
1m ago
8K
LTRN
Lantern Pharma Advances AI-Driven Cancer Therapies
PremiumCompany Announcements
Lantern Pharma Advances AI-Driven Cancer Therapies
7h ago
LTRN
Lantern Pharma reports Q3 EPS (42c), one estimate (56c)
PremiumThe Fly
Lantern Pharma reports Q3 EPS (42c), one estimate (56c)
14h ago
LTRN
Lantern Pharma granted fast track designation for LP-184
PremiumThe Fly
Lantern Pharma granted fast track designation for LP-184
24d ago
LTRN
Lantern Pharma Q2 Results and LP-300 Clinical Trial Update
PremiumCompany Announcements
Lantern Pharma Q2 Results and LP-300 Clinical Trial Update
3M ago
8K
LTRN
Lantern Pharma reports Q2 EPS (46c), one estimate (55c)
PremiumThe FlyLantern Pharma reports Q2 EPS (46c), one estimate (55c)
3M ago
LTRN
Lantern Pharma highlights ‘promising’ prelinical results of LP-184
Premium
The Fly
Lantern Pharma highlights ‘promising’ prelinical results of LP-184
3M ago
LTRN
Lantern updates ongoing Phase 2 HARMONIC trial for ‘Never Smokers’
Premium
The Fly
Lantern updates ongoing Phase 2 HARMONIC trial for ‘Never Smokers’
3M ago
LTRN
Lantern progresses toward diagnostic for LP-184 for oncology clinical trials use
PremiumThe Fly
Lantern progresses toward diagnostic for LP-184 for oncology clinical trials use
4M ago
LTRN
Lantern receives certificate of patent from Japan Patent Office for LP-284
PremiumThe Fly
Lantern receives certificate of patent from Japan Patent Office for LP-284
5M ago
LTRN
Lantern Pharma files $150M mixed securities shelf
PremiumThe Fly
Lantern Pharma files $150M mixed securities shelf
6M ago
LTRN
Lantern Pharma reports Q1 EPS (51c) , one estimate (43c)
PremiumThe Fly
Lantern Pharma reports Q1 EPS (51c) , one estimate (43c)
6M ago
LTRN
Lantern Pharma enters AI-driven collaboration with Oregon Therapeutics
PremiumThe FlyLantern Pharma enters AI-driven collaboration with Oregon Therapeutics
6M ago
LTRN
Lantern Pharma receives regulatory approval to expand Harmonic trial
Premium
The Fly
Lantern Pharma receives regulatory approval to expand Harmonic trial
7M ago
LTRN
Lantern Pharma’s Triple Threat: Inflation, Global Tensions, and Pandemic Impacts Jeopardize Financial Health
Premium
Company Announcements
Lantern Pharma’s Triple Threat: Inflation, Global Tensions, and Pandemic Impacts Jeopardize Financial Health
8M ago
LTRN
Lantern Pharma Announces Fiscal Year and Q4 Results Webinar
PremiumCompany Announcements
Lantern Pharma Announces Fiscal Year and Q4 Results Webinar
8M ago
8K
LTRN
Lantern Pharma reports Q4 EPS (39c), two estimates (40c)
PremiumThe Fly
Lantern Pharma reports Q4 EPS (39c), two estimates (40c)
8M ago
LTRN
Lantern Pharma doses first two patients in LP-284 trial
PremiumThe Fly
Lantern Pharma doses first two patients in LP-284 trial
8M ago
LTRN
LTRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LTRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
LTRN
Lantern Pharma generates new class of ADCs with cryptophycin drug-payload
PremiumThe FlyLantern Pharma generates new class of ADCs with cryptophycin drug-payload
9M ago
LTRN
Lantern Pharma receives Orphan Drug Designation from FDA for LP-284
Premium
The Fly
Lantern Pharma receives Orphan Drug Designation from FDA for LP-284
11M ago
LTRN
Lantern Pharma treatment of diffuse large B-cell lymphoma granted orphan status
Premium
The Fly
Lantern Pharma treatment of diffuse large B-cell lymphoma granted orphan status
12M ago
LTRN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >